Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Biocryst Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get BCRX alertsThomas R. Staab II is recorded as CFO at Biocryst Pharmaceuticals Inc (BCRX). The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $692,790 for Thomas R. Staab II in fiscal 2020, including a base salary of $77,113. Disclosed compensation is on record for 4 fiscal years. Biocryst Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Biocryst Pharmaceuticals Inc includes Charles Gayer (CEO and Board Member), Charlie Gayer (CEO and Board Member), Vincent J. Milano (Chairman and Board Member) and 7 others.
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Biocryst Pharmaceuticals Inc (BCRX) | Former Senior Vice President and Chief Financial Officer | $77,113 | $692,790 |
| 2019 | Biocryst Pharmaceuticals Inc (BCRX) | Former Senior Vice President and Chief Financial Officer | $462,679 | $910,354 |
| 2018 | Biocryst Pharmaceuticals Inc (BCRX) | Former Senior Vice President and Chief Financial Officer | $449,203 | $1,797,270 |
| 2017 | Biocryst Pharmaceuticals Inc (BCRX) | Senior Vice President and Chief Financial Officer | $434,002 | $1,723,588 |
No call appearances or filed executive changes recorded yet.